Stephens Inc’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-59,443
Closed -$48K 1240
2020
Q2
$48K Sell
59,443
-37,275
-39% -$31.5K ﹤0.01% 1092
2020
Q1
$67K Sell
96,718
-8,328
-8% -$10.2K ﹤0.01% 1008
2019
Q4
$166K Sell
105,046
-18,046
-15% -$50.5K ﹤0.01% 1028
2019
Q3
$489K Sell
123,092
-10,442
-8% -$60.7K 0.01% 761
2019
Q2
$967K Sell
133,534
-105,334
-44% -$719K 0.02% 580
2019
Q1
$1.58M Sell
238,868
-973
-0.4% -$6.41K 0.04% 456
2018
Q4
$1.72M Buy
239,841
+48,007
+25% +$535K 0.05% 395
2018
Q3
$3.66M Buy
+191,834
New +$6.85M 0.09% 270
2017
Q3
Sell
-84,502
Closed -$4.11M 919
2017
Q2
$4.11M Buy
84,502
+8,033
+11% +$473K 0.14% 165
2017
Q1
$5.54M Sell
76,469
-3,841
-5% -$254K 0.2% 113
2016
Q4
$4.59M Buy
80,310
+69,010
+611% +$6.32M 0.19% 120
2016
Q3
$1.45M Buy
11,300
+1,914
+20% +$245K 0.06% 301
2016
Q2
$1.17M Buy
9,386
+1,305
+16% +$150K 0.05% 328
2016
Q1
$676K Buy
+8,081
New +$666K 0.03% 408
2015
Q2
Sell
-4,350
Closed -$743K 861
2015
Q1
$743K Buy
+4,350
New +$659K 0.03% 420
2014
Q1
Sell
-8,190
Closed -$1.43M 934
2013
Q4
$1.43M Buy
8,190
+1,521
+23% +$261K 0.07% 266
2013
Q3
$1.08M Buy
6,669
+852
+15% +$134K 0.06% 304
2013
Q2
$773K Buy
+5,817
New +$821K 0.04% 338

Other funds holding ELGX

Stephens Inc's ELGX Position: Q3 2020 in Review

Stephens Inc sold out of Endologix Inc (ELGX) in Q3 2020, closing a stake of 59,443 shares — an estimated $48K sold.

Stephens Inc first reported a position in ELGX in Q2 2013 and held it in 18 quarters. The position peaked at $5.54M in Q1 2017. 6 funds tracked by Wall St. Rank hold ELGX as of Q3 2020.

  • Stephens Inc reported no remaining Endologix Inc position as of Q3 2020 after selling out during the quarter.
  • Stephens Inc sold 59,443 Endologix Inc shares in Q3 2020, an estimated $48K.
  • Stephens Inc first reported a position in Endologix Inc in Q2 2013 and held it in 18 quarters.
  • Stephens Inc's Endologix Inc position peaked at $5.54M in Q1 2017.
  • 6 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2020.

Based on Stephens Inc's 13F filing for Q3 2020, filed 13 Nov 2020.